The boost came in the days after DexCom reported a 64% increase in sales during its 2nd quarter, during which the company also pared losses by more than 40%.
In total DexCom reported losses of $6 million, or 9¢ per share, on sales of $58.8 million during the 3 months ended June 30, 2014. That compares with losses of $10.1 million, or 14¢ per share, on sales of $35.8 million during the same period last year.
DexCom also announced another data partnership to tie the company’s mobile app platform, currently under development, with Asante Solutions’ Snap Insulin Pumps. The Asante partnership is DexCom’s 2nd, following a couple of deals with former development partner Insulet (NSDQ:PODD).
DXCM shares have gained more than 18% in the last week following the financial report and news of the data deals. The stock closed at $44.25 Friday night after opening at $37.48 on Monday, August 4. Shares slid 0.9% today to trade at $43.86 as of about 1:30 p.m. EST.